questionText: To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the adequacy of supply of medicines treating type-2 diabetes in the context of fluctuating levels of demand.
answerText: We are aware of a supply issue with glucagon-like peptide-1 receptor agonists, which has been largely driven by off-label use for weight loss. We have issued guidance in the form of Medicine Supply Notifications and, on 18 July, issued a National Patient ...
heading: Diabetes: Drugs